Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-HOBA in Familial Hypercholesterolemia
NCT04941599Phase 2Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-hydroxybenzylamine in familial hypercholesterolemia (FH), sponsored by Vanderbilt University Medical Center. Started Feb 2024; status: recruiting.
02
Drugs
2-hydroxybenzylamine
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT04941599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941599.